NO20053111L - Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering. - Google Patents

Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.

Info

Publication number
NO20053111L
NO20053111L NO20053111A NO20053111A NO20053111L NO 20053111 L NO20053111 L NO 20053111L NO 20053111 A NO20053111 A NO 20053111A NO 20053111 A NO20053111 A NO 20053111A NO 20053111 L NO20053111 L NO 20053111L
Authority
NO
Norway
Prior art keywords
cell
peptides
inhibit angiogenesis
invasion
migration
Prior art date
Application number
NO20053111A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053111D0 (no
Inventor
Robert J Ternansky
Andrew Mazar
Patricia L Gladstone
Amy L Allan
Sean M O'hare
Fernando Donate
Marian Plunkett
Stephanie A Hopkins
Won Hyung Yoon
Graham Parry
Original Assignee
Attenuon Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Attenuon Llc filed Critical Attenuon Llc
Publication of NO20053111D0 publication Critical patent/NO20053111D0/no
Publication of NO20053111L publication Critical patent/NO20053111L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO20053111A 2002-11-25 2005-06-24 Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering. NO20053111L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42917402P 2002-11-25 2002-11-25
US47553903P 2003-06-02 2003-06-02
PCT/US2003/038175 WO2004047771A2 (en) 2002-11-25 2003-11-25 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof

Publications (2)

Publication Number Publication Date
NO20053111D0 NO20053111D0 (no) 2005-06-24
NO20053111L true NO20053111L (no) 2005-08-24

Family

ID=32397181

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20053111A NO20053111L (no) 2002-11-25 2005-06-24 Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.
NO20053112A NO20053112L (no) 2002-11-25 2005-06-24 Peptider som malsoker tumor- og endotelceller, sammensetninger og anvendelser av slike.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20053112A NO20053112L (no) 2002-11-25 2005-06-24 Peptider som malsoker tumor- og endotelceller, sammensetninger og anvendelser av slike.

Country Status (14)

Country Link
US (2) US20050020810A1 (bg)
EP (2) EP1594521A4 (bg)
JP (2) JP2006514116A (bg)
KR (2) KR20050096917A (bg)
AU (2) AU2003297609A1 (bg)
BR (2) BR0316523A (bg)
CA (2) CA2507045A1 (bg)
EA (2) EA200500870A1 (bg)
HR (2) HRP20050585A2 (bg)
MX (2) MXPA05005545A (bg)
NO (2) NO20053111L (bg)
NZ (2) NZ540889A (bg)
PL (2) PL377701A1 (bg)
WO (2) WO2004063213A2 (bg)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0316523A (pt) * 2002-11-25 2005-10-18 Attenuon Llc Composto, composição farmacêutica e método para tratar ou prevenir câncer em um paciente
US20050260557A1 (en) * 2004-05-21 2005-11-24 Mary Zacour Method of quantifying the cell-binding properties of a medical device
US20060078535A1 (en) * 2004-10-13 2006-04-13 The Regents Of The University Of Michigan Anticancer compounds and methods
JP2008528630A (ja) * 2005-02-01 2008-07-31 アテニュオン，エルエルシー 抗血管新生ｐｈｓｃｎペプチドを含む組成物
WO2006084016A1 (en) 2005-02-01 2006-08-10 Attenuon, Llc ACID ADDITION SALTS OF Ac-PHSCN-NH2
CN101541743A (zh) * 2006-11-08 2009-09-23 于崇曦 多肽及相关化合物的透皮给药系统
AU2016213759B2 (en) * 2006-11-08 2018-03-29 Chongxi Yu Transdermal delivery systems of peptides and related compounds
PL2427475T3 (pl) 2009-05-08 2021-07-19 Techfields Biochem Co., Ltd. Kompozycje proleku o wysokim przenikaniu peptydów i związków powiązanych z peptydami
KR101228668B1 (ko) 2010-09-17 2013-01-31 가톨릭대학교 산학협력단 혈관신생 억제 활성을 갖는 펩타이드 및 이의 용도
US11435358B2 (en) 2011-06-23 2022-09-06 Board Of Regents, The University Of Texas System Single molecule peptide sequencing
US9625469B2 (en) 2011-06-23 2017-04-18 Board Of Regents, The University Of Texas System Identifying peptides at the single molecule level
CN102417540A (zh) * 2011-11-21 2012-04-18 中国药科大学 一种聚乙二醇修饰的整合素阻断剂hm-3及其应用
CN104428014B (zh) * 2012-05-11 2016-11-09 梅迪卡斯生物科学有限责任公司 针对视网膜脱离的生物相容性水凝胶治疗
WO2014139012A1 (en) 2013-03-15 2014-09-18 Suncor Energy Inc. Herbicidal compositions
JP5970439B2 (ja) * 2013-09-20 2016-08-17 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
CA3208970A1 (en) 2014-09-15 2016-05-06 Board Of Regents, The University Of Texas System Improved single molecule peptide sequencing

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
EP0051682B1 (en) * 1980-05-13 1984-09-05 Mitsubishi Kasei Corporation Cysteine derivatives and process for their preparation
US4394519A (en) * 1982-01-19 1983-07-19 Research Corporation Amino acid blocking agents
GB8504253D0 (en) * 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
DE3815221C2 (de) * 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US5091176A (en) * 1988-11-02 1992-02-25 W. R. Grace & Co.-Conn. Polymer-modified peptide drugs having enhanced biological and pharmacological activities
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5229366A (en) * 1990-10-23 1993-07-20 Fuji Photo Film Co., Ltd. Peptide-containing polyethylene glycol derivatives and application thereof
US5149801A (en) * 1990-11-21 1992-09-22 The Regents Of The University Of California Boronated porphyrin compounds
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
US5639725A (en) * 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
CA2215331C (en) * 1995-03-14 2002-01-22 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosating unit
WO1996028205A1 (en) * 1995-03-14 1996-09-19 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosing unit
US5618513A (en) * 1995-06-07 1997-04-08 Mallinckrodt Medical, Inc. Method for preparing radiolabeled peptides
MY147327A (en) * 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
AU4412297A (en) * 1996-09-10 1998-04-02 Burnham Institute, The Tumor homing molecules, conjugates derived therefrom, and methods of using sa me
US6331409B1 (en) * 1996-11-21 2001-12-18 The Regents Of The University Of Michigan Methods and compositions for wound healing
US6001965A (en) * 1996-11-21 1999-12-14 The Regents Of The University Of Michigan Anticancer compounds and methods
US6025150A (en) * 1996-11-21 2000-02-15 The Regents Of The University Of Michigan Methods and compositions for wound healing
DE69824352T2 (de) * 1997-01-14 2005-06-30 Kaneka Corp. Verfahren zur herstellung von cystein derivaten
US5994309A (en) * 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
AU9477398A (en) * 1997-09-10 1999-03-29 Burnham Institute, The Methods of identifying molecules that home to angiogenic vasculature in tumors
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
WO2000009537A2 (en) * 1998-08-14 2000-02-24 Administrators Of The Tulane Educational Fund Compounds having growth hormone releasing activity
EP1388013B1 (en) 2001-01-18 2007-07-11 The Regents Of The University Of Michigan Compositions and methods for the use of fibronectin fragments in the diagnosis of cancer
BR0316523A (pt) * 2002-11-25 2005-10-18 Attenuon Llc Composto, composição farmacêutica e método para tratar ou prevenir câncer em um paciente

Also Published As

Publication number Publication date
KR20050097494A (ko) 2005-10-07
US20050020810A1 (en) 2005-01-27
CA2507045A1 (en) 2004-06-10
NO20053112L (no) 2005-08-05
PL377763A1 (pl) 2006-02-20
US20040162239A1 (en) 2004-08-19
NO20053112D0 (no) 2005-06-24
BR0316550A (pt) 2005-10-04
WO2004047771A3 (en) 2005-09-15
KR20050096917A (ko) 2005-10-06
HRP20050585A2 (en) 2006-02-28
HRP20050584A2 (hr) 2006-04-30
EP1569678A2 (en) 2005-09-07
EA200500871A1 (ru) 2006-04-28
EP1594521A4 (en) 2008-01-09
MXPA05005469A (es) 2005-09-08
WO2004063213A3 (en) 2005-03-03
AU2003297609A1 (en) 2004-06-18
JP2006514116A (ja) 2006-04-27
EP1569678A4 (en) 2008-01-02
EA200500870A1 (ru) 2006-04-28
WO2004063213A2 (en) 2004-07-29
US7517855B2 (en) 2009-04-14
NZ540889A (en) 2008-09-26
NO20053111D0 (no) 2005-06-24
NZ540363A (en) 2007-11-30
AU2003298726A1 (en) 2004-08-10
CA2506813A1 (en) 2004-07-29
MXPA05005545A (es) 2005-10-18
WO2004047771A2 (en) 2004-06-10
PL377701A1 (pl) 2006-02-06
EP1594521A2 (en) 2005-11-16
JP2006515866A (ja) 2006-06-08
BR0316523A (pt) 2005-10-18

Similar Documents

Publication Publication Date Title
NO20053111L (no) Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
NO20072352L (no) Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet
JO2764B1 (en) Indole derivatives or benzimidazole derivatives to modify the enzyme AKP kinase
NO20081421L (no) Midler for hindring og behandling av forstyrrelser som involverer modulering av RYR-reseptorer
TW200509910A (en) Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists
RS20060320A (en) Substituted indazole-o-glucosides
MY169308A (en) Treatment of tnf? related disorders
NO20044658L (no) Anvendelse av osteoprotegerin til behandling og/eller forhindring av fibrotiske sykdommer
SG130189A1 (en) Substituted indole-o-glucosides
NO20052595L (no) Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser.
JO2481B1 (en) Silo cano-indol compounds have fluoride substitution and formulations containing such compounds and their treatment methods
GB0222495D0 (en) Compounds
NO20070782L (no) Tetrapeptidanaloger.
SE0202241D0 (sv) Novel Compounds
EA200870292A1 (ru) Соединения на основе имидазола, композиции, содержащие их, и способы их применения
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
UA86599C2 (en) Substituted benzimidazole-, benztriazole- and benzimidazolone-о-glucosides
NO20054371L (no) Somatostatin-dopamin kimaere analoger
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
CY1108221T1 (el) Μεθοδος για την αναπαραγωγη πλευρομουτιλινων
EP1594509A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF IRRITABLE COLON SYNDROME AND NON ULCEREUS DYSPEPSIS
ATE410235T1 (de) Behandlung von ballastwasser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application